Immatics (IMTX) Interest Coverage Ratio (QoQ) (2019 - 2025)
Immatics (IMTX) Interest Coverage Ratio (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Immatics | 1.11 Bn | 1.11 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8.58% |
| Sep 30, 2025 | 4,166.90% |
| Jun 30, 2025 | 1.71% |
| Mar 31, 2025 | -86.04% |
| Dec 31, 2024 | 2,351.58% |
| Sep 30, 2024 | -98.01% |
| Jun 30, 2024 | 1,579.97% |
| Mar 31, 2024 | -64.69% |
| Dec 31, 2023 | -43.68% |
| Sep 30, 2023 | -20.85% |
| Jun 30, 2023 | 239.68% |
| Mar 31, 2023 | 216.70% |
| Dec 31, 2022 | -111.63% |
| Sep 30, 2022 | 50.09% |
| Jun 30, 2022 | 142.99% |
| Mar 31, 2022 | -244.19% |
| Dec 31, 2021 | -67.21% |
| Sep 30, 2021 | 270.69% |
| Jun 30, 2021 | 119.90% |
| Mar 31, 2021 | 138.74% |